开发和评估多模型信息精确剂量工具,以优化儿童患者的万科米辛治疗
Yawen Yuan1, Li Xu2, Yueling Xi3
1Department of Clinical Pharmacy, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Therapeutic drug monitoring
|October 8, 2025
概括
这项研究开发了一种针对儿童的万科米辛精确剂量工具,提高了药物度的准确性. 与标准剂量方法相比,基于RShiny的工具提高了与标准剂量方法相比,科米辛的目标达到.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 计算生物学 计算生物学
背景情况:
- 儿童患者的万科米辛剂量是具有挑战性的,因为狭窄的治疗窗口和高的药理动力学可变性.
- 低于最佳的万科米辛最低度需要剂量调整,影响治疗的有效性和安全性.
- 制定精确的剂量策略对于优化儿童的万科米辛治疗至关重要.
研究的目的:
- 确定和评估预测性儿科万科米辛药理学 (PK) 模型.
- 开发和验证基于RShiny的多模型精确剂量 (多MIPD) 工具,用于Vancomycin.
- 将多MIPD工具的性能与实证剂量策略进行比较.
主要方法:
- 系统的文献搜索儿科万科米辛PK模型,然后进行质量评估.
- 对治疗药物监测数据的回顾性分析,以评估模型性能.
- 使用追溯和前数据集开发和验证基于RShiny的多MIPD工具.
主要成果:
- 在回顾性数据中,九个万科米辛PK模型显示出出色的预测性能.
- 开发的多MIPD工具在预测未来数据集中的万科米辛度方面表现出高准确性.
- 与实证剂量相比,平均共识模型显著改善了曲线下的目标区域.
结论:
- 基于RShiny的多MIPD工具为儿科患者提供了准确的万科米辛度预测.
- 这种精确剂量方法显著提高了与经验剂量相比,科米辛的目标达到.
- 多MIPD工具代表了对儿童更有效和个性化的万科米辛剂量策略.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
235
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
235
01:29Drug Dosing: Infants and Children
253
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
253
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
218
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
218
01:28Dosage Regimens: Designs and Approaches
261
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
261
01:24Dosage Regimen: Individualization
166
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
166